Is MEDVi Legit? 2026 Review of the GLP-1 Provider
MEDVi is one of the most searched GLP-1 telehealth providers in 2026. We reviewed their licensing, pharmacy partners, pricing, and real patient experiences to give you a straight answer: yes, MEDVi is legitimate — with a few important caveats.
Medically reviewed by Dr. A. Goher, MD. Sources cited from PubMed & FDA.gov. See our standards
Quick Answer: Is MEDVi Legit?
Yes, MEDVi is a legitimate licensed telehealth provider. They are LegitScript certified, operate with licensed U.S. physicians across 49 states, and dispense compounded semaglutide through FDA-registered pharmacy partners. MEDVi earns an 8.9/10 in our independent review, and holds a strong 4.4/5 on Trustpilot from 14,466 reviews. Two things to know before you sign up: refill pricing jumps to $299/month after the first month, and MEDVi received an FDA warning letter on February 20, 2026 over misleading marketing claims (MARCS-CMS 721455) — a labeling/advertising issue, not a safety or contamination finding (full details below). Our top pick for most patients is TrimRx with personalized MD consultations and transparent all-inclusive pricing.
Verified Trustpilot rating: 4.4/5 “Excellent”
Independently of MEDVi's own marketing, its Trustpilot profile shows 4.4/5 from 14,466 reviews — one of the largest verified review bases of any GLP-1 provider we track (you can check it here). About 79% are 5-star and roughly 12% are 1-star. Reviewers praise the fast, easy online process and attentive providers; the recurring complaint is billing — surprise charges before a refill is requested, difficulty cancelling before being billed, and disputed refunds. The billing complaints line up with the $179-to-$299 refill jump we flag above, so confirm your recurring price and cancellation terms before you subscribe.
Methodology note: MEDVi uses Trustpilot's invited-review program, which tends to surface satisfied customers — weight the billing complaints accordingly.
FDA Warning Letter (February 20, 2026)
On February 20, 2026, the FDA issued MEDVi, LLC a warning letter over misleading marketing — not a safety, quality, or contamination problem. The FDA raised two specific issues:
- • The "MEDVi" name shown on product labels implied MEDVi compounds the medications itself, which the FDA said is misleading because it does not.
- • Claims that the products contain the "same active ingredient as Wegovy and Ozempic" implied the compounded drugs are FDA-approved — compounded medications are not FDA-approved.
The FDA calls this "misbranding" and gave MEDVi 15 working days to respond. What it means for you: MEDVi remains a licensed, LegitScript-certified telehealth provider with a 4.4/5 Trustpilot rating — this is nota warning about the safety of the medication itself. But read MEDVi's marketing critically: compounded semaglutide and tirzepatide are the same molecule as the brand drugs, yet they are not FDA-approved.
What Is MEDVi?
MEDVi is a U.S.-based telehealth platform specializing in GLP-1 weight loss programs using compounded semaglutide, available in both injectable and oral dissolving tablet formats.
MEDVi operates across 49 states and connects patients with licensed physicians who evaluate their health history, prescribe appropriate GLP-1 medications, and provide ongoing support through unlimited doctor visits and 24/7 messaging. The company markets itself as a full-service weight loss platform — not just a prescription service — with clinical oversight built into every plan.
MEDVi is LegitScript certified, a credential that requires verified compliance with U.S. pharmacy laws, transparent business practices, and validated prescribing procedures. LegitScript certification is one of the strongest third-party legitimacy signals in the telehealth space, used by Google and payment processors to screen platforms.
Their medication is compounded semaglutide — the same active ingredient as Ozempic and Wegovy — produced by FDA-registered compounding pharmacies. MEDVi offers both weekly injectable semaglutide and oral dissolving tablets (a needle-free alternative), giving them broader appeal than providers offering only injectables.
Is MEDVi Safe?
Yes, MEDVi is safe for most patients when used under the medical supervision their platform provides. The key safety indicators are all positive.
Safety Indicators We Verified
- LegitScript certified— MEDVi has passed LegitScript's rigorous compliance review, which includes verifying U.S. pharmacy licensing, prescriber credentials, and lawful dispensing practices.
- FDA-registered pharmacy partners — MEDVi sources compounded semaglutide from FDA-registered facilities operating under 503A/503B standards, not unregulated or overseas suppliers.
- Licensed U.S. physicians — Every prescription is reviewed by a licensed physician. MEDVi offers unlimited doctor visits and 24/7 messaging for ongoing clinical oversight.
- Required medical intake — MEDVi requires patients to complete a comprehensive health questionnaire, including medical history and contraindications screening, before any prescription is issued.
- No prescription without consultation — Unlike grey-market platforms, MEDVi requires a legitimate prescription from a licensed provider before dispensing.
The medication itself — compounded semaglutide — carries the same side effect profile as brand-name Ozempic and Wegovy (nausea, GI upset, injection site reactions) because it contains the same active molecule. These are manageable for most patients and typically resolve within the first 2-4 weeks. See our GLP-1 side effects guide for a full breakdown.
MEDVi Pricing
MEDVi pricing: $179 for the first month (includes medication, consultation, and shipping), then $299/month for refills. No insurance accepted — cash-pay only.
| Item | MEDVi | TrimRx |
|---|---|---|
| First month | $179 | $179 |
| Refills | $299/mo | $179+/mo (flat) |
| Consultation | Included | Personalized, included |
| Shipping | Free | Free |
| Oral option | Yes (dissolving tablet) | No |
| Insurance | Not accepted | Not accepted |
| Pricing transparency | Price jumps after month 1 | All-inclusive, no hidden fees |
MEDVi's $179 first-month price is compelling, but the jump to $299/month for refills is a significant consideration for long-term users. Over 6 months, MEDVi costs approximately $1,674 ($179 + 5 × $299) vs. TrimRx's $1,074 ($179 flat × 6) on the same timeline. If cost predictability matters, TrimRx or Yucca Health at $146/mo offer meaningfully better long-term value.
MEDVi Pros and Cons
Pros
- ✓Low $179 first-month price includes medication and consultation
- ✓Both injectable and oral dissolving tablet options
- ✓Unlimited doctor visits and 24/7 messaging support
- ✓LegitScript certified for transparency and compliance
Cons
- ✕Refill price jumps to $299/month after the first month
- ✕Cash-pay only — no insurance accepted
- ✕Received an FDA warning letter (Feb 2026) over website marketing claims on compounded GLP-1s — part of an industry-wide sweep of 30+ telehealth firms; concerned labeling/claims, not medication safety
MEDVi — $179 First Month
Injectable + oral options. Unlimited doctor visits. LegitScript certified.
Common Questions and Red Flags People Search About MEDVi
We analyzed the most common search queries about MEDVi to address the real concerns patients have before signing up.
Is MEDVi a scam?
No. MEDVi is not a scam. They hold LegitScript certification, require a legitimate prescription, partner with licensed U.S. pharmacies, and have verifiable business credentials. Scam GLP-1 sites typically lack these markers — they ship without prescriptions, hide their pharmacy partners, and cannot be verified through LegitScript. MEDVi passes all these checks.
Does MEDVi actually work?
MEDVi prescribes compounded semaglutide — the same active ingredient as Ozempic and Wegovy. Clinical evidence supports 12-15% body weight loss over 6 months with semaglutide. The outcomes from compounded semaglutide mirror brand-name results in real-world use because the molecule is identical.
Is MEDVi's compounded semaglutide safe?
MEDVi sources from FDA-registered compounding pharmacies. Their LegitScript certification specifically requires verified compliance with pharmacy regulations. We have not found any FDA warning letters or adverse event reports specifically linked to MEDVi's pharmacy partners. The medication is the same active ingredient as brand-name semaglutide with the same known side effect profile.
What happens if I cancel MEDVi?
MEDVi operates on a cancel-anytime basis — you are not locked into a long-term contract. You can pause or cancel through their patient portal. Note that because MEDVi requires the $299/month refill price after the first month, many patients evaluate whether alternatives offer better ongoing value before committing beyond month one.
MEDVi vs. Alternatives
How does MEDVi compare to the top-rated GLP-1 providers? Here are three tracked alternatives we independently rate higher for long-term value.
TrimRx
9.3/10Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
From $179/mo
Trimi
9.2/10Compounded GLP-1 from $99 with US-licensed clinicians
From $99/mo
SkinnyRx
8.9/10Fastest-growing GLP-1 provider — oral, sublingual, and injectable options with Affirm financing
From $199/mo
How to Sign Up for MEDVi
Signing up for MEDVi takes approximately 10-15 minutes online.
- Visit MEDVi and start the intake form — Answer questions about your health history, current medications, weight loss goals, and medical conditions. MEDVi uses this to screen for contraindications (e.g., personal or family history of thyroid cancer, pancreatitis, type 1 diabetes).
- Choose your medication format — MEDVi offers both injectable compounded semaglutide (weekly subcutaneous injection) and oral dissolving tablets (sublingual). Select based on your preference.
- Complete payment — $179 covers your first month including medication, consultation, and free shipping. MEDVi does not accept insurance — HSA/FSA cards may be eligible.
- Physician review — A licensed physician reviews your intake and issues a prescription, typically within 24-48 hours. They may message you with follow-up questions.
- Receive your medication — MEDVi ships directly to your door via temperature-controlled packaging. Most patients receive their first shipment within 3-5 business days.
- Begin treatment and check in — MEDVi includes unlimited doctor visits and 24/7 messaging for dose adjustments, side effect management, and questions.
MEDVi FAQ
Has MEDVi received an FDA warning letter?
Yes. On February 20, 2026, the FDA issued MEDVi, LLC a warning letter over misleading marketing — product labels implying MEDVi compounds the drugs itself, and claims implying its compounded semaglutide and tirzepatide are FDA-approved. It is a misbranding (advertising/labeling) issue, not a safety, quality, or contamination finding. MEDVi remains a licensed, LegitScript-certified provider with a 4.4/5 Trustpilot rating; the letter is a reason to read its marketing critically, not evidence the medication is unsafe.
Does MEDVi accept insurance?
No. MEDVi is cash-pay only and does not accept insurance. The $179 first-month price and $299/month refills are all-inclusive (medication, consultation, shipping). HSA/FSA cards are typically accepted as a form of payment since GLP-1 medications qualify as a medical expense.
Does MEDVi offer oral GLP-1 options?
Yes. MEDVi is one of the few GLP-1 telehealth providers offering oral dissolving tablets (sublingual semaglutide) in addition to the standard weekly injectable. This makes MEDVi a good option for patients with needle aversion. Oral bioavailability is slightly lower than injectable, but clinical outcomes are comparable for most patients.
Can I get a refund from MEDVi?
MEDVi's refund policy covers situations where medication is not dispensed or there are verified fulfillment errors. Once a prescription has been filled and shipped, refunds are typically not issued for the medication itself. Before signing up, confirm MEDVi's current refund terms directly on their site, as policies can change.
How fast does MEDVi ship?
MEDVi ships via temperature-controlled packaging and most patients receive their first order within 3-5 business days after prescription approval. Physician review typically takes 24-48 hours, so total time from sign-up to delivery is generally 5-7 business days.
What are MEDVi's side effects?
MEDVi prescribes compounded semaglutide, which carries the same side effect profile as brand-name Ozempic and Wegovy: nausea (most common, affecting 30-40% of patients), diarrhea, constipation, vomiting, headache, and injection site reactions. Most GI side effects resolve within 2-4 weeks as your body adjusts to the medication. MEDVi's 24/7 messaging allows you to report side effects and get dose adjustments promptly.
Ready to try MEDVi?
LegitScript certified · $179 first month · Injectable + oral options